Canlyniadau Chwilio - Michael A. Pulsipher
- Dangos 1 - 20 canlyniadau o 123
- Ewch i'r Dudalen Nesaf
-
1
Hypogammaglobulinemia due to CAR T‐cell therapy gan Andrew Doan, Michael A. Pulsipher
Cyhoeddwyd 2017Carta -
2
-
3
-
4
Allogeneic Transplantation for Pediatric Acute Lymphoblastic Leukemia: The Emerging Role of Peritransplantation Minimal Residual Disease/Chimerism Monitoring and Novel Chemotherape... gan Michael A. Pulsipher, Peter Bader, Thomas Klingebiel, Laurence J.N. Cooper
Cyhoeddwyd 2009Revisão -
5
-
6
Concerns about the use of biosimilar granulocyte colony-stimulating factors for the mobilization of stem cells in normal donors: position of the World Marrow Donor Association gan B. E. Shaw, Dennis L. Confer, William Ying Khee Hwang, Derwood Pamphilon, Michael A. Pulsipher
Cyhoeddwyd 2011Revisão -
7
NCI, NHLBI/PBMTC First International Conference on Late Effects after Pediatric Hematopoietic Cell Transplantation: Health-Related Quality of Life, Functional, and Neurocognitive O... gan Susan K. Parsons, Sean Phipps, Lillian Sung, K. Scott Baker, Michael A. Pulsipher, Kirsten K. Ness
Cyhoeddwyd 2011Artigo -
8
NCI, NHLBI/PBMTC First International Conference on Late Effects after Pediatric Hematopoietic Cell Transplantation: Endocrine Challenges—Thyroid Dysfunction, Growth Impairment, Bon... gan Christopher C. Dvorak, Clarisa R. Gracia, Jean E. Sanders, Edward Y. Cheng, K. Scott Baker, Michael A. Pulsipher, Anna Petryk
Cyhoeddwyd 2011Artigo -
9
Practice patterns for evaluation, consent, and care of related donors and recipients at hematopoietic cell transplantation centers in the United States gan Paul V. O’Donnell, Tanya L. Pedersen, Dennis L. Confer, J. Douglas Rizzo, Michael A. Pulsipher, David Stroncek, Susan F. Leitman, Paolo Anderlini
Cyhoeddwyd 2010Artigo -
10
National Cancer Institute–National Heart, Lung and Blood Institute/Pediatric Blood and Marrow Transplant Consortium First International Consensus Conference on Late Effects After P... gan Michael L. Nieder, George B. McDonald, Aiko Kida, Sangeeta Hingorani, Saro H. Armenian, Kenneth R. Cooke, Michael A. Pulsipher, K. Scott Baker
Cyhoeddwyd 2011Artigo -
11
High-Risk Neuroblastoma Treated With Tandem Autologous Peripheral-Blood Stem Cell–Supported Transplantation: Long-Term Survival Update gan Rani E. George, Shuli Li, Cheryl Medeiros-Nancarrow, Donna Neuberg, Karen Marcus, Robert C. Shamberger, Michael A. Pulsipher, Stephan A. Grupp, Lisa Diller
Cyhoeddwyd 2006Artigo -
12
Effect of Antithymocyte Globulin Source on Outcomes of Bone Marrow Transplantation for Severe Aplastic Anemia gan Joseph H. Antin, H. Joachim Deeg, Sandra Korman, Carmem Bonfim, Ryotaro Nakamura, Mary M. Horowitz, Daniel J. Weisdorf, Mary Eapen, Michael A. Pulsipher
Cyhoeddwyd 2014Artigo -
13
Donor, recipient, and transplant characteristics as risk factors after unrelated donor PBSC transplantation: beneficial effects of higher CD34+ cell dose gan Michael A. Pulsipher, Pintip Chitphakdithai, Brent R. Logan, Susan F. Leitman, Paolo Anderlini, John P. Klein, Mary M. Horowitz, J. Philip Miller, Roberta King, Dennis L. Confer
Cyhoeddwyd 2009Artigo -
14
National Institutes of Health Hematopoietic Cell Transplantation Late Effects Initiative: The Cardiovascular Disease and Associated Risk Factors Working Group Report gan Saro H. Armenian, Wassim Chemaitilly, Marcus Y. Chen, Eric J. Chow, Christine Duncan, Lee W. Jones, Michael A. Pulsipher, Alan T. Remaley, Alicia Rovó, Nina Salooja, Minoo Battiwalla
Cyhoeddwyd 2016Artigo -
15
Myeloid lineage switch following chimeric antigen receptor T‐cell therapy in a patient with TCF3‐ZNF384 fusion‐positive B‐lymphoblastic leukemia gan Matthew J. Oberley, Paul S. Gaynon, Deepa Bhojwani, Michael A. Pulsipher, Rebecca Gardner, Matthew Hiemenz, Jianling Ji, Jennifer Han, Maurice R.G. O’Gorman, Alan S. Wayne, Gordana Raca
Cyhoeddwyd 2018Artigo -
16
Hematopoietic cell transplantation‐comorbidity index and Karnofsky performance status are independent predictors of morbidity and mortality after allogeneic nonmyeloablative hemato... gan Mohamed L. Sorror, Barry E. Storer, Brenda M. Sandmaier, David G. Maloney, Thomas R. Chauncey, Amelia Langston, Richard T. Maziarz, Michael A. Pulsipher, Peter A. McSweeney, Rainer Storb
Cyhoeddwyd 2008Artigo -
17
Lower risk for serious adverse events and no increased risk for cancer after PBSC vs BM donation gan Michael A. Pulsipher, Pintip Chitphakdithai, Brent R. Logan, Willis H. Navarro, John E. Levine, J. Philip Miller, Bronwen E. Shaw, Paul V. O’Donnell, Navneet S. Majhail, Dennis L. Confer
Cyhoeddwyd 2014Artigo -
18
The Role of Cytotoxic Therapy with Hematopoietic Stem Cell Transplantation in the Treatment of Pediatric Acute Lymphoblastic Leukemia: Update of the 2005 Evidence-Based Review gan Denise M Oliansky, Bruce Camitta, Paul S. Gaynon, Michael L. Nieder, Susan K. Parsons, Michael A Pulsipher, Hildy Dillon, Thomas A Ratko, Donna A. Wall, Philip L. McCarthy, Theresa Hahn
Cyhoeddwyd 2012Revisão -
19
Immunogenicity of CAR T cells in cancer therapy gan Dimitrios L. Wagner, Enrico Fritsche, Michael A. Pulsipher, Nabil Ahmed, Mohamad Hamieh, Meenakshi Hegde, Marco Ruella, Barbara Savoldo, Nirali N. Shah, Cameron J. Turtle, Alan S. Wayne, Mohamed Abou‐El‐Enein
Cyhoeddwyd 2021Revisão -
20
Reduced-intensity allogeneic transplantation in pediatric patients ineligible for myeloablative therapy: results of the Pediatric Blood and Marrow Transplant Consortium Study ONC03... gan Michael A. Pulsipher, Kenneth M. Boucher, Donna A. Wall, Haydar Frangoul, Michel Duval, Rakesh K. Goyal, Peter J. Shaw, Ann E. Haight, Michael Grimley, Stephan A. Grupp, Morris Kletzel, Richard Kadota
Cyhoeddwyd 2009Artigo
Offerynnau Chwilio:
Pynciau Perthynol
Medicine
Internal medicine
Transplantation
Hematopoietic stem cell transplantation
Biology
Immunology
Oncology
Genetics
Stem cell
Chemotherapy
Surgery
Haematopoiesis
Leukemia
Hematopoietic cell
Gastroenterology
Cyclophosphamide
Disease
Pediatrics
Bone marrow
Lymphoblastic Leukemia
Fludarabine
Immune system
Intensive care medicine
Biochemistry
Gene
Physics
Total body irradiation
Graft-versus-host disease
Clinical trial
Acute lymphocytic leukemia